Entera Bio (ENTX) Revenue (2018 - 2025)
Entera Bio (ENTX) recorded quarterly Revenue of $42000.0 in Q1 2025, down 48.78% on a QoQ basis from $82000.0 in Q4 2024.
Entera Bio (ENTX) Revenue (2018 - 2025) Analysis & Trends
Entera Bio has disclosed Revenue across 5 years of filings, most recently posting $42000.0 for Q1 2025.
- Quarterly Revenue changed N/A year-over-year to $42000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $42000.0 (down 76.8% YoY) and the FY2025 annual result came in at $42000.0, down 76.8% from the prior year.
- Revenue slipped to $42000.0 in Q1 2025, from $82000.0 in the prior quarter.
- Over five years, Revenue peaked at $165000.0 in Q4 2021 and troughed at $8000.0 in Q3 2022.
- A 4-year average of $77333.3 and a median of $62500.0 in 2022 frame the typical range for Revenue.
- Biggest YoY gain for Revenue was 56.69% in 2022; the steepest drop was 94.29% in 2022.
- Tracing ENTX's Revenue over 4 years: stood at $165000.0 in 2021, then plunged by 91.52% to $14000.0 in 2022, then soared by 485.71% to $82000.0 in 2024, then sank by 48.78% to $42000.0 in 2025.
- Business Quant data shows ENTX's Revenue at $42000.0 in Q1 2025, $82000.0 in Q4 2024, and $42000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | 82,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 44,000.00 |
| Mar 31, 2022 | 68,000.00 |
| Dec 31, 2021 | 165,000.00 |
| Sep 30, 2021 | 140,000.00 |
| Jun 30, 2021 | 109,000.00 |
| Mar 31, 2021 | 157,000.00 |
| Dec 31, 2018 | 500,000.00 |